Mitchell Clark

Integrated mutational landscape analysis of uterine leiomyosarcomas

Jungmin Choi, Aránzazu Manzano, Weilai Dong et al. · Proceedings of the National Academy of Sciences · 2021 · 113 citations · Full text

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

Stefania Bellone, Dana M. Roque, Eric R. Siegel et al. · Cancer · 2021 · 72 citations · Full text

Dual-Targeting Nanoparticles for <i>In Vivo</i> Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

Emiliano Cocco, Yang Deng, Erik M. Shapiro et al. · Molecular Cancer Therapeutics · 2016 · 37 citations · Full text

Nanotherapeutics, Engineering, Molecular Biology +17

Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu

Ghanshyam S. Yadav, Dana M. Roque, Stefania Bellone et al. · Gynecologic Oncology · 2022 · 34 citations

Uterine Serous Carcinoma, Synergistic Activity, Medicine +6

Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu

Joan Tymon‐Rosario, Eric R. Siegel, Stefania Bellone et al. · Gynecologic Oncology · 2021 · 28 citations · Full text

Trastuzumab Tolerability, Gynecological Surgery, Medicine +5